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between immunoparalysis and delirium 
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Abstract 
Background: Delirium occurs frequently following cardiothoracic surgery, and infectious disease is an important 
risk factor for delirium. Surgery and cardiopulmonary bypass induce suppression of the immune response known as 
immunoparalysis. We aimed to investigate whether delirious patients had more pronounced immunoparalysis follow-
ing cardiothoracic surgery than patients without delirium, to explain this delirium-infection association.
Methods: A prospective matched case–control study was performed in two university hospitals. Cytokine produc-
tion (tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-8 and IL-10) of ex vivo lipopolysaccharide (LPS)-stimulated 
whole blood was analyzed in on-pump cardiothoracic surgery patients preoperatively, and at 5 timepoints up to 
3 days after cardiothoracic surgery. Delirium was assessed by trained staff using two validated delirium scales and 
chart review.
Results: A total of 89 patients were screened of whom 14 delirious and 52 non-delirious patients were included. 
Ex vivo-stimulated production of TNF-α, IL-6, IL-8, and IL-10 was severely suppressed following cardiothoracic surgery 
compared to pre-surgery. Postoperative release of cytokines in non-delirious patients was attenuated by 84% [IQR: 
13–93] for TNF-α, 95% [IQR: 78–98] for IL-6, and 69% [IQR: 55–81] for IL-10. The attenuation in ex vivo-stimulated pro-
duction of these cytokines was not significantly different in patients with delirium compared to non-delirious patients 
(p > 0.10 for all cytokines).
Conclusions: The post-operative attenuation of ex vivo-stimulated production of pro- and anti-inflammatory 
cytokines was comparable between patients that developed delirium and those who remained delirium-free after 
on-pump cardiothoracic surgery. This finding suggests that immunoparalysis is not more common in cardiothoracic 
surgery patients with delirium compared to those without.
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Introduction
Delirium, characterized by an acute onset of inattention 
and other cognitive deficits, is a common postoperative 
complication in cardiothoracic surgery patients with 
an incidence of 10–20% [1]. Delirium is associated with 
multiple impaired outcomes, such as increased risk of 
dementia and prolonged admission with associated costs 
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[2, 3]. Previous studies showed that various pro- and anti-
inflammatory mediators may be associated with delirium 
[4–6], and these may also account for the development of 
immunoparalysis [7–9]. This suppression of the immune 
response has also been shown in other states to be asso-
ciated with severe systemic inflammation, e.g. sepsis, and 
is associated with an increased susceptibility to second-
ary infections and morbidity [10]. Interestingly, patients 
with delirium appear to be prone to develop a secondary 
infection, but also an infectious disease is a risk factor for 
delirium [3]. The interplay between immunoparalysis and 
delirium has not been investigated previously.
Cardiothoracic surgery results in a systemic inflamma-
tory response that could also lead to an innate immune 
response in the brain, called neuroinflammation [11] 
that may clinically express as delirium [12]. In addition, 
several studies have demonstrated that the use of cardio-
pulmonary bypass (CPB) disturbs the balance between 
pro- and anti-inflammatory responses, which may induce 
suppression of the immune responses postoperatively [8, 
9, 13, 14].
Given the association between severe inflammation 
and the development of both delirium and immunopa-
ralysis, we aimed to test the hypothesis that cardiac sur-
gery-induced immunoparalysis is more pronounced in 




This multicenter, prospective, observational case–control 
study was performed in two University Medical Centers 
in the Netherlands: Radboud University Medical Center 
Nijmegen and University Medical Center Utrecht. The 
study was approved by the medical ethical committees 
in both centers and the need for informed consent was 
waived (study number 2012/297 and 12/471).
Eligible patients were aged 50 years or older, scheduled 
to undergo on-pump coronary artery bypass grafting 
(CABG) or single heart valve surgery, and delirium-free 
prior to the operation. Exclusion criteria were combined 
CABG with valve surgery for reason of group homogene-
ity, use of blood cardioplegia since this type of cardiople-
gia is associated with the development of postoperative 
neurological events [15], a pre-operative diagnosis con-
sistent with immune suppression, inability to screen for 
delirium, pre-operative infection (determined by positive 
blood cultures or by administration of antibiotics), and 
a history of cognitive impairment or psychiatric illness 
for reason of group homogeneity. Dexamethasone was 
the only anti-inflammatory medication administrated to 
all patients during surgery as standard practice in both 
centers. Cefazolin was used for perioperative antibiotic 
prophylaxis.
Patients who developed delirium postoperatively 
were defined as ‘cases’ and patients who did not develop 
delirium served as ‘non-cases’. The group of cases was 
matched to non-cases for which propensity matching 
was used. Propensity scoring parameters were the follow-
ing pre-operative and postoperative risk factors for delir-
ium [3] gender, age, duration of surgery, extracorporeal 
circulation (ECC) time, aortic cross clamp (AOX) time, 
risk of death after cardiac surgery (European System for 
Cardiac Operative Risk Evaluation (EuroSCORE-II) and 
severity of illness score (Acute Physiology and Chronic 
Health Evaluation (APACHE)-II score).
Delirium diagnosis
Patients were assessed for delirium three times a day by 
trained nurses and researchers, using validated delir-
ium assessment tools. In the Intensive Care Unit (ICU) 
the Confusion Assessment Method Intensive Care Unit 
(CAM-ICU) [16] was used, and on the cardiothoracic 
surgery ward the Delirium Observation Screening (DOS) 
scale [17] In order to increase the delirium detection rate, 
patients’ medical and nursing records were evaluated for 
delirium signs by the investigators and for delirium treat-
ment. Delirium was defined as having a positive CAM-
ICU assessment or a DOS score ≥ 3, use of haloperidol 
for no other reason than delirium treatment, or when 
there were typical signs of delirium registered without a 
positive delirium assessment.
Data collection and variables
Demographic and clinical data were obtained from elec-
tronic patient files. Blood was sampled from the central 
venous catheter, and if this was not possible, from an 
indwelling arterial catheter or by vena puncture at six 
time points: preoperatively, i.e. immediately after the 
induction of anesthesia, but prior to incision  (T0), within 
one hour following post-operative ICU admission  (T1), 
6 h after ICU admission  (T6), and 24 (T24), 48  (T48) and 
72 h (T72) after cardiothoracic surgery.
Ex‑vivo cytokine production
Immunoparalysis is characterized by attenuated cytokine 
production following ex vivo leukocyte stimulation with 
bacterial lipopolysaccharide (LPS) [7]. Lithium hepa-
rin (LH) anti-coagulated blood was obtained for ex vivo 
stimulation experiments, which were performed imme-
diately after sampling. Leukocyte cytokine production 
capacity was determined by challenging whole blood 
from the patients with LPS ex  vivo using an in-house 
developed system with prefilled tubes described in detail 
elsewhere [18]. Briefly, 0.5  mL of blood was added to 
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tubes prefilled with 2  mL culture medium as negative 
control or 2  mL culture medium supplemented with 
Escherichia coli LPS (serotype O55:B5 (Sigma Aldrich, St 
Louis, MO, USA)), resulting in a final LPS concentration 
of 10 ng/mL. Cultures were incubated at 37 °C for 24 h, 
centrifuged, and supernatants were stored at − 80 °C until 
analysis. Concentrations of IL-6, IL-8, IL-10 and TNF-α, 
were determined batchwise by ELISA according to the 
manufacturer’s instructions (R&D systems, Minneapolis, 
MN, USA). Cytokine concentrations were normalized to 
monocyte counts since these cells are the main cytokine-
producing cells in whole blood stimulation assays [19].
Statistical analysis
Demographic and patient characteristics were reported 
as means with standard deviation (SD), medians with 
interquartile range [IQR], or frequencies, depending on 
data distribution or occurrence. Accordingly, the Stu-
dent’s t-test, Mann–Whitney U test, or Fischer’s exact 
test were used for group comparisons. Propensity scores 
were calculated using logistic regression analysis with 
‘delirium’ or ‘no delirium’ as dependent variable and 
the delirium risk factors; age, APACHE-II score, AOX-
time and EuroSCORE-II, as independent variables. 
Linear mixed effects models were used to study associa-
tions between the trajectory of log-transformed ex  vivo 
cytokine concentrations and the occurrence of postop-
erative delirium. The time of sampling and the occur-
rence of delirium (yes/no) were analyzed as fixed effects, 
while subject ID was entered as random effect. Statisti-
cal significance was defined as a p value of < 0.05. Statisti-
cal analysis was performed using R, version 3.6.2 (http:// 
www.R- proje ct. org) software packages, and IBM SPSS 
Statistics 20 (IBM, NY, USA). Figures were created in 




A total of 89 cardiothoracic surgery patients were 
screened of whom 18 (20%) developed delirium postop-
eratively. One non-delirious patient was excluded due 
to a postoperative cerebral infarction, twelve non-delir-
ious and four delirious patients were excluded because 
of absent cytokine data. Subsequently 14 cases were 
matched with 52 non-delirious cases. Nine patients 
developed delirium within 24  h and five patients devel-
oped delirium within 72  h after surgery. No significant 
differences were found in demographic characteristics 
between delirious and non-delirious patients (Table  1). 
None of the participants were discharged on antipsy-
chotic therapy.
Ex vivo cytokine production
Both groups showed a swift, profound and statistically 
significant attenuation of ex  vivo-stimulated cytokine 
(TNF-α, IL-6, IL-8, and IL-10) production directly at 
ICU admission after surgery (Fig.  1). For all cytokines, 
the recovery of cytokine producing capacity started from 
24  h onwards. However, TNF-α and IL-10 productions 
were still significantly suppressed 72 h after surgery com-
pared to the first preoperative baseline measurement 
(−  44% [95% CI −  60 to −  21%], p < 0.001, and −  33% 
[95% CI − 51 to − 9%], p = 0.01, respectively).
Ex vivo-stimulated cytokine production pre- and 
postoperatively were not significantly different between 
Table 1 Demographic variables of delirious and non-delirious patients
AOX, aortic cross-clamping; APACHE-II, Acute Physiology and Chronic Health Evaluation II score; BMI, body mass index; CABG, coronary artery bypass grafting surgery; 
EuroSCORE-II, European System for Cardiac Operative Risk Evaluation-II; IQR, interquartile range; SD, standard deviation
a Unpaired t-test; bFisher’s exact test; cMann–Whitney U test
Non‑delirious patients (n = 52) Delirious patients (n = 14) p‑value
Age (years), mean (SD) 65 (8.2) 68 (6.9) 0.196a
Sex, male, n (%) 37 (71) 9 (64) 0.745b
BMI, kg/m2, mean (SD) 28 (4.7) 28 (4.3) 0.636a
Type of surgery 0.536b
 CABG, n (%) 35 (67) 8 (57)
 Aortic valve, n (%) 17 (33) 6 (43)
Duration of surgery, minutes, mean (SD) 203 (53) 196 (65) 0.700a
Perfusion time, minutes, median [IQR] 90 [72–107] 82 [69–117] 0.790c
AOX time, median [IQR] 63 [52–78] 62 [48–75] 0.505c
APACHE-II score, median [IQR] 17 [14–29] 19 [16–42] 0.243c
EuroSCORE-II, mean (SD) 3.4 (2.3) 4.3 (2.0) 0.209a
Preoperative plasma creatinine level, μmol/L, median [IQR] 84 [75–96] 85 [70–103] 0.947c
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delirious and non-delirious patients (difference between 
groups: TNF-α (p = 0.10), IL-6 (p = 0.42), IL-8.
(p = 0.13), and IL-10 (p = 0.87), Fig. 1).
Discussion
This study suggests that the extent of postoperative 
immunoparalysis is similar in patients that develop 
delirium, compared to those who do not. This indi-
cates that immunoparalysis does not play an important 
role in the pathogenesis of delirium and presumably 
not in the development of secondary infections that are 
more frequently observed in patients suffering from 
delirium. In addition, our data confirms previous stud-
ies [14, 20–23] that the ex  vivo-stimulated production 
of both pro-inflammatory (IL-6, IL-8 and TNF-α) and 
anti-inflammatory (IL-10) cytokines are severely sup-
pressed following on-pump cardiothoracic surgery.
To our knowledge, it has not been studied previously 
to what extent ex vivo-stimulated cytokine production is 
attenuated in patients with and without delirium follow-
ing cardiac surgery. Elevated plasma concentrations of 
TNF-α, IL-6 and IL-8 were reported to be associated with 
delirium [4–6, 24, 25]. In our study we did not analyze 
the in  vivo plasma levels of pro- and anti-inflammatory 
cytokines since our aim was to determine whether or 
not immunoparalysis was more pronounced in patients 
with delirium after cardiothoracic surgery. Additionally, 
plasma concentrations of cytokines are not a sensitive 
hallmark of immunoparalysis [26].
This study has several limitations. First, although delir-
ium was not diagnosed by an delirium expert such as a 
Fig. 1 Cytokine producing capacity in delirious and non-delirious patients, after whole blood ex vivo-stimulation with bacterial lipopolysaccharide. 
A Tumor necrosis factor-α (TNF-α). B Interleukin-6 (IL-6). C IL-8. D IL-10. Data are expressed as median concentration per  106 monocytes 
[interquartile range]. The blue dotted rectangles illustrate the duration of surgery. *p < 0.05; **p < 0.01; ***p < 0.001, NS: no significant change from 
baseline, according to linear mixed model analysis (LMM) with time of sampling and delirium occurrence as fixed variables, and subject ID as 
random effect. The p-values above each graph indicate no significant differences in the trajectories of ex vivo cytokine production between patients 
with and without postoperative delirium based on the LMM analysis, described above
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psychiatrist, neurologist or geriatrician, we used vali-
dated and frequently used delirium assessment tools for 
this purpose [16, 17], that were applied by trained (ICU) 
nurses and researchers. This was complemented by a 
detailed assessment of the medical and nursing files for 
notes on delirium and treatment with haloperidol in 
order not to miss any patients with delirium. Second is 
the relative small number of patients. However, with our 
standardized and robust methodology of ex vivo immu-
nostimulation, combined with our matched case–con-
trol design, we were able to find a homogenous immune 
response with small margin of error between patients 
with and without delirium. Based on our data, we do 
not expect that a larger number of patients would likely 
change our results. Third, in the current study all patients 
were treated with dexamethasone per-operatively, while 
dexamethasone inhibits LPS-stimulated production of 
TNF-α, IL-6, IL-8 and IL-10 [27–29]. However, previ-
ous research demonstrated that immunoparalysis occurs 
after cardiothoracic surgery irrespective of corticoster-
oids use [14, 20–23]. Finally, the incidence of secondary 
infections after cardiac surgery is low [30, 31], and the 
power of this cohort was insufficient to analyze associa-
tions between delirium, secondary infections and immu-
noparalysis. This renders us unable to draw conclusions 
on whether or not immunoparalysis is involved in the 
pathogenesis of secondary infections that are more fre-
quently observed in patients suffering from delirium. 
Alternatively, acute malnutrition, dehydration and aspi-
ration pneumonia are common in delirious patients and 
may explain the increased susceptibility to secondary 
infections in delirium [32].
Conclusion
The time-course of ex  vivo-stimulated production of 
pro- and anti-inflammatory cytokines was compara-
ble between delirious and non-delirious patients in on-
pump post cardiothoracic surgery patients. This finding 
indicates that immunoparalysis is not more pronounced 
in cardiothoracic surgery patients with delirium than in 
those without.
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